India to Ethiopia: Glibenclamide Export Trade Route

The India to Ethiopia Glibenclamide corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $106.1K USD. The route is dominated by MEDICAMEN BIOTECH LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's glibenclamide manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $26.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with glibenclamide's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 22.4%, placing it at rank #11 among India's top glibenclamide export destinations globally.

On the import side, key buyers of Indian glibenclamide in Ethiopia include NA, TO THE ORDER OF. NA is the single largest importer with 1 shipments valued at $62.1K USD.

India's glibenclamide exports to Ethiopia are driven primarily by a handful of large-scale manufacturers. MEDICAMEN BIOTECH LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Ethiopia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDICAMEN BIOTECH LIMITED — together account for 100% of total trade value on this route. The average shipment value of $26.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as glibenclamide tablets bp 5 mg 10x10,batch no.nt50219 to nt50223, mfg dt.01/03/2025, exp dt.28/02/2028 and glibenclamide tablets bp 5 mg(10x10)each uncoated tab. contains:glibenclamidebp 5 mg,b-nt50218,mfg-1-3-25,exp-28-2-28, suggesting that buyers in Ethiopia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 1 shipments worth $62.1K USD — representing 59% of all glibenclamide imports from India on this route.